Breast cancer: research without consent.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer
- Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations
- Cohort profile: the MCC-Spain follow-up on colorectal, breast and prostate cancers: study design and initial results
- BRCA1, BRCA2 and CHEK2 c.1100 delC mutations in patients with double primaries of the breasts and/or ovaries
- A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer
- High frequency of BRCA1/2 germline mutations in 42 Belgian families with a small number of symptomatic subjects
- Coverage of common cancer types in UK national newspapers: a content analysis
- Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status
- Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies
- Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility